• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与早期类风湿关节炎诊断时间相关的因素。

Factors associated with time to diagnosis in early rheumatoid arthritis.

机构信息

Departments of Medicine and Community Health Sciences, University of Calgary, 3330 Hospital Dr NW, Calgary, AB, T2N 4N1, Canada,

出版信息

Rheumatol Int. 2014 Jan;34(1):85-92. doi: 10.1007/s00296-013-2846-5. Epub 2013 Aug 30.

DOI:10.1007/s00296-013-2846-5
PMID:23989941
Abstract

Early diagnosis and treatment yield optimal outcomes in rheumatoid arthritis (RA); thus, barriers to disease recognition must be identified and addressed. We determined the impact of sociodemographic factors, medical comorbidities, family history, and disease severity at onset on the time to diagnosis in early RA. The Canadian early ArThritis CoHort study data on 1,142 early RA patients were analyzed for predictors of time to diagnosis using regression analysis. Sociodemographic factors (age, sex, income strata, education, ethnicity), measures of disease activity (joint counts, DAS28 score, acute-phase reactants, patient global evaluation, function), family history, serology, chronic musculoskeletal and mental health conditions, and obesity at diagnosis were considered. In multivariate linear regression analysis, more swollen joints (β = -0.047 per joint, 95 % CI -0.085, -0.010, p = 0.014), higher erythrocyte sedimentation rate (ESR) (β = -0.012 per 1 mm/h, 95 % CI -0.022, -0.002, p = 0.0018), and worse patient global scores (β = -0.082 per 1 unit on a visual analogue scale, 95 % CI -0.158, -0.006, p = 0.034) at baseline predicted a shorter time to diagnosis. Anti-cyclic citrullinated peptide (anti-CCP) antibody positivity (β = 0.688, 95 % CI 0.261, 1.115, p = 0.002) and low income (annual <$20,000 β = 1.185, 95 % CI 0.227, 2.143, p = 0.015; annual $20,000-50,000 β = 0.933, 95 % CI 0.069, 1.798, p = 0.034) increased time to diagnosis. In the logistic regression models, the odds of being diagnosed within 6 months of symptom onset were increased for each swollen joint present [odds ratio (OR) 1.04, 95 % CI 1.02-1.06 per joint], each 1 mm/h elevation in the ESR (OR 1.01, 95 % CI 1.00-1.02), and decreased for patients who were either rheumatoid factor or anti-CCP positive compared to both factors being negative (OR 0.68, 95 % CI 0.51-0.91). Higher disease activity results in a more rapid diagnosis for Canadian patients with early RA, but those with lower income have delays in diagnosis. Strategies to identify patients with a less severe disease presentation and in lower socioeconomic strata are needed to ensure equal opportunity for optimal management.

摘要

早期诊断和治疗可使类风湿关节炎(RA)获得最佳疗效;因此,必须识别和解决疾病认知的障碍。我们确定了社会人口统计学因素、合并症、家族史和发病时疾病严重程度对早期 RA 诊断时间的影响。使用回归分析对加拿大早期关节炎队列研究的 1142 例早期 RA 患者的数据进行了分析,以确定诊断时间的预测因素。考虑了社会人口统计学因素(年龄、性别、收入阶层、教育、种族)、疾病活动度测量(关节计数、DAS28 评分、急性期反应物、患者整体评估、功能)、家族史、血清学、慢性肌肉骨骼和心理健康状况以及诊断时的肥胖。在多元线性回归分析中,更多的肿胀关节(每关节增加 0.047 个,95%CI-0.085,-0.010,p=0.014)、更高的红细胞沉降率(ESR)(每增加 1 毫米/小时增加 0.012 个,95%CI-0.022,-0.002,p=0.0018)和更差的患者整体评分(每增加 1 个单位的视觉模拟量表增加 0.082 个,95%CI-0.158,-0.006,p=0.034)在基线时预测诊断时间更短。抗环瓜氨酸肽(抗-CCP)抗体阳性(β=0.688,95%CI 0.261,1.115,p=0.002)和低收入(年收入<20,000 美元β=1.185,95%CI 0.227,2.143,p=0.015;年收入 20,000-50,000 美元β=0.933,95%CI 0.069,1.798,p=0.034)增加了诊断时间。在逻辑回归模型中,与两种因子均为阴性相比,每出现一个肿胀关节,发病后 6 个月内被诊断的可能性就会增加[优势比(OR)1.04,95%CI 1.02-1.06/关节],ESR 每升高 1 毫米/小时(OR 1.01,95%CI 1.00-1.02),患病的可能性就会增加。与两种因子均为阴性相比,类风湿因子或抗-CCP 阳性的患者的诊断时间更短(OR 0.68,95%CI 0.51-0.91)。加拿大早期 RA 患者疾病活动度越高,诊断速度越快,但收入较低的患者诊断时间延迟。需要制定策略来识别疾病表现较轻和社会经济地位较低的患者,以确保有平等的机会获得最佳管理。

相似文献

1
Factors associated with time to diagnosis in early rheumatoid arthritis.与早期类风湿关节炎诊断时间相关的因素。
Rheumatol Int. 2014 Jan;34(1):85-92. doi: 10.1007/s00296-013-2846-5. Epub 2013 Aug 30.
2
Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.类风湿关节炎的放射学结局可通过疾病发作前及发作时抗环瓜氨酸肽抗体的存在情况以及疾病发作时的IgA类风湿因子来预测。
Ann Rheum Dis. 2006 Apr;65(4):453-8. doi: 10.1136/ard.2005.041376. Epub 2005 Sep 21.
3
Longitudinal study of clinical prognostic factors in patients with early rheumatoid arthritis: the PREDICT study.早期类风湿关节炎患者临床预后因素的纵向研究:PREDICT研究
Int J Rheum Dis. 2017 Apr;20(4):460-468. doi: 10.1111/1756-185X.13036. Epub 2017 Feb 16.
4
Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.相比于抗环瓜氨酸肽抗体,抗突变型瓜氨酸波形蛋白抗体在预测早期类风湿关节炎24个月时的疾病活动方面表现更佳。
J Rheumatol. 2008 Jun;35(6):1002-8. Epub 2008 Apr 1.
5
Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up.抗II型胶原蛋白抗体与急性起病的类风湿关节炎表型相关,且在5年随访期间预示着较低的炎症程度。
Ann Rheum Dis. 2017 Sep;76(9):1529-1536. doi: 10.1136/annrheumdis-2016-210873. Epub 2017 Mar 23.
6
The presence of anti-citrullinated protein antibodies (ACPA) and rheumatoid factor on patients with rheumatoid arthritis (RA) does not interfere with the chance of clinical remission in a follow-up of 3 years.类风湿关节炎患者存在抗瓜氨酸化蛋白抗体 (ACPA) 和类风湿因子并不会影响其在 3 年随访期间达到临床缓解的机会。
Rheumatol Int. 2012 Dec;32(12):3807-12. doi: 10.1007/s00296-011-2260-9. Epub 2011 Dec 21.
7
Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in Iranian patients with rheumatoid arthritis: evaluation of clinical value and association with disease activity.伊朗类风湿关节炎患者的抗环瓜氨酸肽抗体和类风湿因子亚型:临床价值评估及与疾病活动度的关联
Iran J Allergy Asthma Immunol. 2014 Jun;13(3):147-56.
8
Easy and accurate diagnosis of rheumatoid arthritis using anti-cyclic citrullinated peptide 2 antibody, swollen joint count, and C-reactive protein/rheumatoid factor.使用抗环瓜氨酸肽2抗体、肿胀关节计数以及C反应蛋白/类风湿因子对类风湿关节炎进行简便而准确的诊断。
J Rheumatol. 2008 Mar;35(3):414-20. Epub 2008 Jan 15.
9
Association of anticyclic citrullinated peptide antibodies and/or rheumatoid factor status and clinical presentation in early arthritis: results from the ESPOIR cohort.早期关节炎中抗环瓜氨酸肽抗体和/或类风湿因子状态与临床表现的关联:ESPOIR队列研究结果
J Rheumatol. 2014 Aug;41(8):1614-22. doi: 10.3899/jrheum.130884. Epub 2014 Jul 15.
10
Diagnostic performance of anti-cyclic citrullinated peptide and rheumatoid factor in patients with rheumatoid arthritis.抗环瓜氨酸肽和类风湿因子在类风湿关节炎患者中的诊断效能
Int J Rheum Dis. 2016 Sep;19(9):880-6. doi: 10.1111/1756-185X.12552. Epub 2015 May 4.

引用本文的文献

1
Sociodemographic and economic barriers to initial specialist care for patients with rheumatoid arthritis: a scoping review.类风湿关节炎患者获得初始专科护理的社会人口学和经济障碍:一项范围综述
BMC Rheumatol. 2025 Jul 1;9(1):76. doi: 10.1186/s41927-025-00501-2.
2
Gender differences in clinical and prescribing characteristics of biologic and targeted synthetic drugs in naïve patients with rheumatoid arthritis: Data from BIOBADASER III registry.初治类风湿关节炎患者使用生物制剂和靶向合成药物的临床及处方特征的性别差异:来自BIOBADASER III注册研究的数据
Arthritis Res Ther. 2025 May 14;27(1):103. doi: 10.1186/s13075-025-03571-2.
3

本文引用的文献

1
Time to disease-modifying antirheumatic drug treatment in rheumatoid arthritis and its predictors: a national, multicenter, retrospective cohort.类风湿关节炎患者接受疾病修饰抗风湿药物治疗的时间及其预测因素:一项全国性、多中心、回顾性队列研究。
J Rheumatol. 2012 Nov;39(11):2088-97. doi: 10.3899/jrheum.120100. Epub 2012 Aug 15.
2
The Canadian Early Arthritis Cohort (CATCH): patients with new-onset synovitis meeting the 2010 ACR/EULAR classification criteria but not the 1987 ACR classification criteria present with less severe disease activity.加拿大早期关节炎队列(CATCH):新发病变关节炎患者符合 2010 年 ACR/EULAR 分类标准,但不符合 1987 年 ACR 分类标准,其疾病活动度较轻。
J Rheumatol. 2012 Nov;39(11):2071-80. doi: 10.3899/jrheum.120029. Epub 2012 Aug 15.
3
Barriers to the Diagnosis of Early Inflammatory Arthritis: A Literature Review.
早期炎性关节炎的诊断障碍:文献综述
Open Access Rheumatol. 2023 Jan 27;15:11-22. doi: 10.2147/OARRR.S282622. eCollection 2023.
4
Understanding sex-related differences in healthcare utilisation among patients with inflammatory arthritis: a population-based study.理解炎症性关节炎患者在医疗保健利用方面的性别差异:一项基于人群的研究。
Ann Rheum Dis. 2023 Feb;82(2):283-291. doi: 10.1136/ard-2022-222779. Epub 2022 Sep 16.
5
A quarter of patients time their early rheumatoid arthritis onset differently than physicians.四分之一的患者的早期类风湿关节炎发病时间与医生的记录不同。
RMD Open. 2019 Nov 14;5(2):e000931. doi: 10.1136/rmdopen-2019-000931. eCollection 2019.
6
The impact of gender on time to rheumatoid arthritis classification: a retrospective analysis of a population-based cohort.性别对类风湿关节炎分类时间的影响:基于人群队列的回顾性分析。
Rheumatol Int. 2019 Dec;39(12):2025-2030. doi: 10.1007/s00296-019-04360-2. Epub 2019 Jul 23.
7
The Influence of Overweight and Obesity on Treatment Response in Juvenile Idiopathic Arthritis.超重和肥胖对幼年特发性关节炎治疗反应的影响
Front Pharmacol. 2019 Jun 12;10:637. doi: 10.3389/fphar.2019.00637. eCollection 2019.
8
Analysis of Socioeconomic Status in the Patients with Rheumatoid Arthritis.类风湿关节炎患者的社会经济地位分析。
Int J Environ Res Public Health. 2018 Jun 7;15(6):1194. doi: 10.3390/ijerph15061194.
9
Diagnostic delays in rheumatic diseases with associated arthritis.伴有相关关节炎的风湿性疾病的诊断延迟。
Reumatologia. 2017;55(4):169-176. doi: 10.5114/reum.2017.69777. Epub 2017 Aug 31.
10
The journey of rheumatoid arthritis patients: a review of reported lag times from the onset of symptoms.类风湿关节炎患者的就医历程:对已报道的症状出现至就诊间隔时间的综述
Open Access Rheumatol. 2017 Jul 28;9:139-150. doi: 10.2147/OARRR.S138830. eCollection 2017.
A systematic literature review of strategies promoting early referral and reducing delays in the diagnosis and management of inflammatory arthritis.炎症性关节炎的早期转诊和减少诊断及管理延误策略的系统文献回顾。
Ann Rheum Dis. 2013 Jan;72(1):13-22. doi: 10.1136/annrheumdis-2011-201063. Epub 2012 Apr 24.
4
Time to consultation and disease-modifying antirheumatic drug treatment of patients with rheumatoid arthritis--northern Alberta perspective.类风湿关节炎患者的就诊时间和改善病情抗风湿药物治疗——艾伯塔省北部的观点。
J Rheumatol. 2012 Apr;39(4):707-11. doi: 10.3899/jrheum.110818. Epub 2012 Feb 15.
5
Delays in help seeking at the onset of the symptoms of rheumatoid arthritis: a systematic synthesis of qualitative literature.类风湿性关节炎症状出现时寻求帮助的延误:定性文献的系统综合。
Ann Rheum Dis. 2012 Apr;71(4):493-7. doi: 10.1136/ard.2011.155416. Epub 2011 Nov 25.
6
Time to treatment for new patients with rheumatoid arthritis in a major metropolitan city.大都市中新类风湿关节炎患者的治疗时间。
J Rheumatol. 2011 Jul;38(7):1282-8. doi: 10.3899/jrheum.101315. Epub 2011 May 15.
7
Treatment of early rheumatoid arthritis: concepts in management.早期类风湿关节炎的治疗:管理中的概念。
Semin Arthritis Rheum. 2011 Apr;40(5):371-88. doi: 10.1016/j.semarthrit.2010.10.004. Epub 2011 Feb 4.
8
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.2010年类风湿关节炎分类标准:美国风湿病学会/欧洲抗风湿病联盟合作项目
Arthritis Rheum. 2010 Sep;62(9):2569-81. doi: 10.1002/art.27584.
9
Long-term impact of delay in assessment of patients with early arthritis.早期关节炎患者评估延迟的长期影响。
Arthritis Rheum. 2010 Dec;62(12):3537-46. doi: 10.1002/art.27692.
10
The influence of ethnicity on the extent of, and reasons underlying, delay in general practitioner consultation in patients with RA.种族对 RA 患者全科医生就诊延迟程度及背后原因的影响。
Rheumatology (Oxford). 2010 May;49(5):1005-12. doi: 10.1093/rheumatology/keq011. Epub 2010 Feb 26.